Credit: PROFESSOR JOHN ZAJICEK/Science Source
And, importantly, view the impact of MS through the eyes of individual patients who generously tell their stories of how they build their lives around their abilities, not their disabilities.
The road to a cure for MS lies ahead. Along the way, clinicians, physicians, and patients are sharing their stories of working toward that goal at The Multiple Sclerosis Journey. We invite you to join them.
Walk with us.
From the multiple sclerosis specialist working in a dedicated MS center, to the rural clinician with the occasional MS patient, there is little debate that infusible disease-modifying therapies (DMTs) have transformed care for this patient population.
John DeLuca, PhD, alternates between frustration and motivation as he talks about cognitive rehabilitation in multiple sclerosis (MS). As a neuropsychologist and senior vice president of research and training at Kessler Foundation in West Orange, N.J., he is a world-renowned expert, making his simple take on the topic particularly appealing.
Warm-weather events, even just unseasonably warm spells, may exacerbate multiple sclerosis (MS) symptoms and may lead to more acute care visits, according to an analysis of patients at the Palo Alto (Calif.) Veterans Affairs clinic. The findings could have implications for patient management, especially in the wake of global warming that will make such patterns more frequent.
A new analysis of the North American Registry for Care and Research in Multiple Sclerosis (NARCRMS), a physician-based longitudinal registry, underscores discrepancies in care between Whites and Blacks and Hispanics. The research also found that Blacks and Hispanics with multiple sclerosis (MS) experience more severe disease and are less likely than Whites to initiate disease-modifying therapies (DMTs).